EZH2 and cancer: In the prostate cancer cell line PC3, the chemical compound triptolide (a promising anti-cancer drug whose mechanisms are not well described but are believed to involve the regulation of caspases, NF-κB pathway, heat-shock proteins, and DNA repair associated factors [52]) decreased mRNA levels of EZH2, and led to an increase in CDH1 expression [53].